Summit Therapeutics Inc. (NASDAQ:SMMT – Get Free Report)’s share price traded up 8.1% during mid-day trading on Wednesday . The company traded as high as $7.92 and last traded at $7.90. 2,589,140 shares traded hands during mid-day trading, a decline of 19% from the average session volume of 3,208,273 shares. The stock had previously closed […]
Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Summit Therapeutics (NASDAQ:SMMT) is a Miami-based biopharmaceutical company that is focused on discovery, development, and the commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States and the .